Flexible Endoscopes Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Flexible Endoscopes Market size stood at USD 13.87 billion in 2026 and is predicted to grow at a 5.66% CAGR from 2027 to 2036, crossing USD 24.05 billion by 2036. The industry revenue for 2027 is calculated at USD 14.53 billion.

• Base Year Value (2026): USD 13.87 billion
• CAGR (2027-2036): 5.66%
• Forecast Year Value (2036): USD 24.05 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Flexible Endoscopes Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America’s leadership is driven by high procedure volumes, advanced hospital infrastructure, and steady replacement demand for upgraded endoscopy systems supporting improved clinical performance and efficiency.
  • Asia Pacific is growing at an 8.7% CAGR due to expanding healthcare access, rising adoption of minimally invasive procedures, and increasing investment in endoscopy-capable medical facilities.

• Segment Momentum:

  • Hospitals accounted for a 62.89% share in 2026 because they manage high procedure volumes, complex diagnostics, multidisciplinary care, and specialized endoscopy services within a single healthcare setting.
  • Laparoscopes are the fastest-growing product segment as healthcare providers increasingly adopt minimally invasive surgical approaches that improve procedural efficiency while reducing surgical disruption.

• Market Expansion Drivers:

  • Growing preference for minimally invasive surgeries increasing flexible endoscope utilization across hospitals.
  • Advancements in AI-enabled imaging and miniaturized endoscopy improving diagnostic precision and procedural efficiency.
  • Rising outpatient and ambulatory surgical center expansion supporting demand for portable endoscopic systems.

• Leading Market Participants:

  Prominent players in the flexible endoscopes market include Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Boston Scientific Corporation (United States), Stryker Corporation (United States), Medtronic plc (Ireland), Ambu A/S (Denmark), PENTAX Medical (Japan), Richard Wolf GmbH (Germany).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 13.87 billion
  • 2027 Estimated Market Size: USD 14.53 billion.
  • Projected Market Size: USD 24.05 billion by 2036
  • Growth Forecasts: 5.66% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | Gastrointestinal Endoscopes (Product)
  • Emerging Opportunity Segment: Outpatient Facilities (End Use) | Laparoscopes (Product)

Market Growth Drivers and Industry Trends

Growing preference for minimally invasive surgeries increasing flexible endoscope utilization across hospitals

The growing preference for minimally invasive procedures will drive the flexible endoscopes market growth as healthcare providers increasingly favor techniques that reduce tissue trauma, shorten recovery periods, and improve patient comfort compared with conventional open surgeries. Flexible endoscopes enable physicians to access difficult anatomical areas through smaller entry points while supporting visualization and targeted interventions across a broad range of diagnostic and therapeutic procedures. Their versatility across specialties such as gastroenterology, pulmonology, urology, and otolaryngology also encourages hospitals to expand endoscopic capabilities, while improvements in image quality and instrument maneuverability make these systems more suitable for increasingly complex procedures.

Advancements in AI-enabled imaging and miniaturized endoscopy improving diagnostic precision and procedural efficiency

Advancements in AI-enabled imaging are strengthening the clinical value of the flexible endoscopes market by helping physicians identify abnormalities more consistently and interpret endoscopic images with greater precision. AI-assisted image analysis can support the detection of subtle lesions and other clinically relevant findings, while miniaturized components allow endoscopic systems to reach anatomically challenging areas with less procedural complexity. Enhanced visualization, automated image interpretation, and improved device maneuverability can also streamline examination workflows, reduce the burden on clinicians, and support more efficient decision-making during diagnostic procedures.

Rising outpatient and ambulatory surgical center expansion supporting demand for portable endoscopic systems

Expansion of outpatient facilities and ambulatory surgical centers will boost flexible endoscopes market demand as healthcare delivery increasingly shifts toward procedures performed outside traditional inpatient hospital settings. These facilities require compact, adaptable, and efficient equipment that can support high procedure volumes while fitting into constrained clinical environments. Flexible endoscopic systems are well suited to such settings because they can facilitate a wide range of diagnostic and minimally invasive interventions without requiring the infrastructure associated with more extensive surgical procedures, encouraging healthcare providers to invest in portable and workflow-oriented endoscopy solutions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing preference for minimally invasive surgeries increasing flexible endoscope utilization across hospitals	2.00%	Moderate	North America, Europe, Asia Pacific	High	Near Term
Advancements in AI-enabled imaging and miniaturized endoscopy improving diagnostic precision and procedural efficiency	1.80%	High	North America, Europe, Asia Pacific	High	Mid Term
Rising outpatient and ambulatory surgical center expansion supporting demand for portable endoscopic systems	1.40%	Moderate	Asia Pacific, North America	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The flexible endoscopes market was led by North America, which held a 43.13% share in 2026. The region's strong market position is supported by advanced healthcare infrastructure, widespread access to specialized diagnostic and surgical procedures, and high adoption of minimally invasive technologies. Healthcare providers are increasingly favoring flexible endoscopic techniques because they can support less invasive examination and treatment while improving procedural efficiency and patient recovery. Ongoing investments in hospital modernization, endoscopy facilities, and advanced medical equipment are further supporting demand. In addition, the presence of experienced gastroenterology and surgical specialists, established reimbursement frameworks, and strong clinical awareness of early disease detection contribute to sustained utilization of flexible endoscopes across diagnostic and therapeutic applications.

Asia Pacific represents the fastest-growing regional market, supported by expanding healthcare infrastructure, improving access to specialized medical services, and rising demand for minimally invasive procedures. Increasing healthcare expenditure and the modernization of hospitals are enabling greater adoption of advanced endoscopic equipment, particularly in developing healthcare systems. Growing awareness of early diagnosis for gastrointestinal and other internal conditions is also encouraging the use of endoscopic procedures. Furthermore, investments in medical technology, expansion of specialist healthcare capacity, and improving patient access to diagnostic services are creating favorable conditions for wider adoption. The region's large patient base and increasing focus on improving clinical outcomes are expected to reinforce demand for flexible endoscopy technologies.

Key Country Insights

United States

Advanced Clinical Adoption

The U.S. flexible endoscopes market emphasizes advanced imaging capabilities and minimally invasive procedures across major healthcare providers. Hospitals and device manufacturers continue investing in technologies that improve diagnostic precision, workflow efficiency, and patient outcomes.

Japan

Imaging Technology Excellence

Japan advances the flexible endoscopes market through continuous refinement of imaging performance, device miniaturization, and physician usability. Japanese manufacturers support healthcare facilities with technologies designed to enhance diagnostic accuracy across multiple specialties.

South Korea

Digital Endoscopy Expansion

South Korea strengthens flexible endoscope adoption by integrating digital imaging technologies with modern hospital infrastructure. Healthcare providers increasingly invest in equipment that improves procedural efficiency while supporting expanded minimally invasive diagnostic services.

Germany

Precision Medical Engineering

Germany focuses on high-performance flexible endoscopes supported by strong medical device engineering and clinical quality standards. German healthcare providers value equipment reliability, advanced visualization, and integration with modern hospital diagnostic systems.

France

Hospital Modernization Priority

France supports flexible endoscope procurement through healthcare modernization efforts focused on diagnostic quality and efficient clinical workflows. French medical facilities emphasize reliable systems that enhance patient care while supporting evolving endoscopy service requirements.

Italy

Procedure Capacity Enhancement

Italy expands the use of flexible endoscopes by improving diagnostic capacity across hospitals and specialized care centers. Italian healthcare providers prioritize versatile endoscopic systems that support efficient procedures, dependable performance, and broad clinical application.

Segment Leadership and Growth Trends

 

End Use Segment Analysis: Hospitals (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)

Hospitals dominated the flexible endoscopes market in 2026, accounting for a 62.89% share. Hospitals remain the primary end users of flexible endoscopy systems because they perform a broad range of diagnostic and therapeutic procedures across multiple medical specialties. The availability of specialized clinical teams, advanced procedure rooms, and comprehensive patient-care infrastructure enables hospitals to support complex endoscopic interventions and routine examinations. Increasing demand for minimally invasive diagnostic techniques is also strengthening the role of flexible endoscopes, which can provide detailed visualization while reducing the need for more invasive surgical approaches. The expanding use of endoscopy in gastrointestinal, respiratory, and other clinical applications continues to sustain demand within hospital settings.

Outpatient facilities are expected to be the fastest-growing end-use segment as healthcare delivery increasingly shifts toward convenient, minimally invasive procedures performed outside traditional inpatient environments. Advances in endoscopic technologies are enabling more procedures to be conducted efficiently in ambulatory settings, supporting shorter patient stays and greater procedural flexibility. Outpatient facilities also benefit from growing patient preference for convenient care and healthcare providers' focus on improving resource utilization. As diagnostic and therapeutic endoscopy becomes increasingly suitable for same-day or short-duration care pathways, demand for flexible endoscopes within outpatient facilities is expected to expand.

Product Segment Analysis: Gastrointestinal Endoscopes (Largest Segment) vs Laparoscopes (Fastest-Growing Segment)

Gastrointestinal endoscopes held the largest share of the flexible endoscopes market in 2026, accounting for a 58.37% share. Their leading position is driven by the extensive use of flexible endoscopic procedures for examining and treating disorders affecting the gastrointestinal tract. These devices support direct visualization of internal anatomy and enable physicians to conduct diagnostic assessments, obtain tissue samples, and perform selected therapeutic procedures with limited invasiveness. Rising demand for early detection and management of gastrointestinal conditions continues to support procedure volumes and related equipment adoption. Technological improvements in imaging quality, maneuverability, and procedural functionality are also strengthening the clinical utility of gastrointestinal endoscopes.

The laparoscopes segment is expected to be the fastest-growing product segment, supported by the broader adoption of minimally invasive surgical techniques. Flexible and advanced laparoscopic technologies can help clinicians perform procedures through smaller access points, potentially supporting reduced tissue trauma and faster recovery compared with conventional open approaches. Increasing preference for minimally invasive interventions across surgical specialties is creating favorable conditions for laparoscope adoption. Continued improvements in visualization, instrument flexibility, and surgical precision are further expanding the applicability of laparoscopic procedures, supporting strong growth in demand for these devices.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End Use	Hospitals, Outpatient Facilities	Hospitals	Outpatient Facilities
Product	Bronchoscopes, Laparoscopes, Laryngoscopes, Otoscopes, Ureteroscopes, Cystoscopes, Nasopharyngoscopes, Rhinoscopes, Arthroscopes, Neuroendoscopes, Hysteroscopes, Gynecology Endoscopes, Gastrointestinal Endoscopes	Gastrointestinal Endoscopes	Laparoscopes

Competitive Landscape and Market Positioning

Leading companies in the flexible endoscopes market:

1. Olympus Corporation (Japan)

2. FUJIFILM Holdings Corporation (Japan)

3. KARL STORZ SE & Co. KG (Germany)

4. Boston Scientific Corporation (United States)

5. Stryker Corporation (United States)

6. Medtronic plc (Ireland)

7. Ambu A/S (Denmark)

8. PENTAX Medical (Japan)

9. Richard Wolf GmbH (Germany)

The flexible endoscopes market is advancing with improved minimally invasive diagnostic tools that enhance procedural accuracy and patient comfort. Continuous innovation in imaging and device flexibility is improving clinical efficiency. The flexible endoscopes market is increasingly shaped by advanced diagnostic endoscopy technologies.

Industry Development/News

Company Name	Date	Key Development
Roen Surgical	Nov-25	Roen Surgical supplied its Zamenix AI-based robotic kidney stone–removal system to Seoul National University Hospital’s training center. This deployment facilitates advanced surgical training for urologists, highlighting the increasing adoption of AI-enabled, fully robotic endoscopic systems designed to enhance procedural precision, reduce surgical trauma, and automate complex stone-removal tasks in minimally invasive urological procedures.
Olympus	May-25	Olympus received FDA 510(k) clearance for its EZ1500 series endoscopes, which integrate Extended Depth of Field (EDOF) technology into the EVIS X1 platform. This innovation allows for simultaneous near- and far-focused imaging, providing clinicians with sharper, wide-depth visuals that aid in the early detection and characterization of GI lesions while reducing the need for manual focus adjustments.
FUJIFILM	May-25	FUJIFILM Healthcare Europe launched the ELUXEO 8000 series (EG-840T and EG-840TP) endoscopes. These therapeutic gastroscopes are engineered for advanced procedural applications, specifically supporting complex gastrointestinal treatments such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), thereby expanding the diagnostic and therapeutic versatility of the ELUXEO imaging ecosystem.
KARL STORZ	Jan-25	KARL STORZ SE & Co. KG completed the strategic acquisition of its long-standing Swiss distributor, ANKLIN. This vertical integration strengthens the company’s direct-to-market presence in Switzerland, enabling improved customer service, tailored MedTech solution delivery, and enhanced operational control over its sales and technical support channels in the region.
Lumicell	Oct-24	Lumicell is developing a novel flexible endoscope for the early detection of esophageal adenocarcinoma (EAC) in Barrett's esophagus patients. Supported by a Phase I SBIR contract from the National Cancer Institute, this R&D initiative aims to introduce high-sensitivity detection capabilities for precancerous lesions, addressing a significant unmet need in the early intervention and management of esophageal malignancies.
KARL STORZ	Aug-24	KARL STORZ U.S. and FUJIFILM Healthcare Americas entered a strategic marketing partnership to provide comprehensive, integrated endoscopic solutions. The collaboration pairs Fujifilm’s flexible gastrointestinal endoscopes with KARL STORZ’s advanced operating room (OR) integration software, offering clinical institutions a unified, high-performance ecosystem for end-to-end surgical visualization and procedural management.
Olympus	Apr-24	Olympus received FDA 510(k) clearance for "RenaFlex," its first single-use flexible ureteroscope system. Designed to address the clinical and economic challenges of reusable scope management, RenaFlex provides high-resolution visualization for the diagnosis and treatment of urinary tract disorders, including kidney stone fragmentation, while eliminating the logistical and reprocessing burdens associated with traditional multi-use devices.
Olympus	Jan-24	Olympus acquired the Korea-based medical device manufacturer Taewoong Medical. This strategic acquisition integrates Taewoong's robust gastrointestinal (GI) stent portfolio into Olympus' existing EndoTherapy business. The deal aims to enhance Olympus’s comprehensive solutions for complex GI procedures, improve clinical outcomes, and strengthen its market-leading position in therapeutic endoscopy.
Boston Scientific	Aug-21	Boston Scientific received regulatory approval for the "EXALT Model B" single-use bronchoscope. Designed as a high-performance alternative to reusable bronchoscopes, this device mitigates cross-contamination risks and streamlines workflow in intensive care and pulmonology settings, marking a strategic expansion of the company’s single-use endoscopy portfolio across multiple critical care segments.
PENTAX Medical	May-21	PENTAX Medical and Vedkang Medical Science and Technology formed a joint venture to develop and commercialize single-use flexible endoscope devices. The partnership leverages Vedkang's manufacturing agility and PENTAX’s clinical expertise to scale the production of disposable endoscopic technologies, aimed at meeting the rising market demand for contamination-free, cost-effective visualization solutions in specialized clinical environments.